X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs MERCK LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER MERCK LTD PFIZER/
MERCK LTD
 
P/E (TTM) x 28.7 33.1 86.6% View Chart
P/BV x 4.6 3.7 123.0% View Chart
Dividend Yield % 0.7 0.8 93.1%  

Financials

 PFIZER   MERCK LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
MERCK LTD
Dec-16
PFIZER/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,060 257.0%   
Low Rs1,611623 258.6%   
Sales per share (Unadj.) Rs440.9632.4 69.7%  
Earnings per share (Unadj.) Rs48.745.7 106.5%  
Cash flow per share (Unadj.) Rs75.862.3 121.6%  
Dividends per share (Unadj.) Rs15.0011.00 136.4%  
Dividend yield (eoy) %0.71.3 52.9%  
Book value per share (Unadj.) Rs462.9388.8 119.1%  
Shares outstanding (eoy) m45.7516.60 275.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 369.5%   
Avg P/E ratio x44.518.4 241.8%  
P/CF ratio (eoy) x28.613.5 211.8%  
Price / Book Value ratio x4.72.2 216.3%  
Dividend payout %30.824.1 128.0%   
Avg Mkt Cap Rs m99,16313,969 709.9%   
No. of employees `0002.91.6 182.5%   
Total wages/salary Rs m2,7581,487 185.5%   
Avg. sales/employee Rs Th6,981.76,631.9 105.3%   
Avg. wages/employee Rs Th954.5939.2 101.6%   
Avg. net profit/employee Rs Th771.1479.4 160.8%   
INCOME DATA
Net Sales Rs m20,17010,498 192.1%  
Other income Rs m857242 353.7%   
Total revenues Rs m21,02810,741 195.8%   
Gross profit Rs m4,3101,135 379.6%  
Depreciation Rs m1,239276 449.6%   
Interest Rs m50-   
Profit before tax Rs m3,9231,102 356.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794343 522.7%   
Profit after tax Rs m2,228759 293.6%  
Gross profit margin %21.410.8 197.6%  
Effective tax rate %45.731.1 146.8%   
Net profit margin %11.07.2 152.8%  
BALANCE SHEET DATA
Current assets Rs m16,2996,410 254.3%   
Current liabilities Rs m7,5948,828 86.0%   
Net working cap to sales %43.2-23.0 -187.3%  
Current ratio x2.10.7 295.6%  
Inventory Days Days6558 113.2%  
Debtors Days Days2638 67.1%  
Net fixed assets Rs m8,6221,406 613.0%   
Share capital Rs m458166 275.6%   
"Free" reserves Rs m20,7226,286 329.7%   
Net worth Rs m21,1806,455 328.1%   
Long term debt Rs m250-   
Total assets Rs m29,1378,828 330.0%  
Interest coverage x755.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.71.2 58.2%   
Return on assets %7.78.6 89.2%  
Return on equity %10.511.8 89.5%  
Return on capital %19.017.1 111.2%  
Exports to sales %0.18.3 0.7%   
Imports to sales %17.521.0 83.1%   
Exports (fob) Rs m12869 1.4%   
Imports (cif) Rs m3,5262,209 159.6%   
Fx inflow Rs m52959 5.4%   
Fx outflow Rs m1402,612 5.4%   
Net fx Rs m-88-1,653 5.3%   
CASH FLOW
From Operations Rs m3,4361,070 321.0%  
From Investments Rs m-6,991-750 932.5%  
From Financial Activity Rs m-619-150 413.1%  
Net Cashflow Rs m-4,174171 -2,442.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.8 123.4%  
Indian inst/Mut Fund % 7.5 18.2 41.2%  
FIIs % 4.9 1.0 490.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 29.1 81.4%  
Shareholders   85,207 28,591 298.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 23, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS